The Approach to High Risk Bladder Cancers in the Absence of Bacillus Calmette Guerin: What should Be the Treatment and Follow Up?
Yükleniyor...
Dosyalar
Tarih
2014
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Galenos Yayincilik
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Bacillus Calmette Guerin (BCG), is the optimal bladder-sparing treatment option for patients with high-risk, non-muscle invasive bladder cancer. Recently, the application of BCG has been hindered due to the problem of its availability in Turkey. Alternative treatment options are needed until this problem is solved. In this article, the recommendations about the preferred treatment options and the follow-up, are summarized in the light of the current literature.
Açıklama
Anahtar Kelimeler
BBCG, high risk non-muscle invasive bladder cancer, EMDA, thermo-chemotherapy
Kaynak
Uroonkoloji Bulteni-Bulletin of Urooncology
WoS Q Değeri
N/A
Scopus Q Değeri
Cilt
13
Sayı
2
